Bronze
| Address | 82, 2sandan-ro, Ochang-eup, Cheongwon-gu, Cheongju-si, Chungcheongbuk-do, Republic of Korea | ||
|---|---|---|---|
| Telephone | +82-43-717-7000 | Fax | +82-2-2216-0357 |
| Website | https://www.celltrionph.com/ | hyeonseong.ryu@celltrionph.com | |
As one of the leading pharmaceutical manufacturers in Korea, Celltrion Pharm supplies chemical pharmaceuticals and biomedicine products inside and outside of Korea. Celltrion Pharm’s competitiveness stems from its outstanding R&D capabilities and high-quality production facilities.
Herzuma® is an oncology mAb biosimilar developed by Celltrion and approved by FDA and EMA. INN : Trastuzumab Indications : HER2-Positive Metastatic Breast Cancer, Early Breast Cancer(EBC), Metastatic Gastric Cancer(MGC) Protein Type : Monoclonal antibody (mAb) Mechanism of Action : It binds to the HER2 receptor overexpressed on the surface of breast cancer cells, as an antibody, to prevent the proliferation and rapid growth of breast cancer cells. Drug Approval Status : Korea, USA, Europe, Japan, Brazil, etc.
